Comparing the Procedural and Clinical Outcomes of Sapien XT and Sapien 3 Valves in Transcatheter Aortic Valve Replacement in Korean Patients.
Hyungdon KookDuck Hyun JangKyung Sook YangHyung Joon JooJae Hyoung ParkSoon Jun HongDo-Sun LimSeung-Hyuk ChoiYoung Jin ChoiKiyuk ChangCheol-Woong YuPublished in: Korean circulation journal (2020)
Cardiovascular mortality was lower in the S3 group than in the SXT group over 1 year of follow-up. The reduction in PVL was attributed to the higher device success rate of TAVR with the S3 valve. However, the benefit of S3 obtained at the expense of reduced EOA should be meticulously re-evaluated in larger studies during long-term follow-up.
Keyphrases
- transcatheter aortic valve replacement
- aortic valve
- aortic stenosis
- transcatheter aortic valve implantation
- aortic valve replacement
- ejection fraction
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- heart failure
- cardiovascular events
- mitral valve
- coronary artery disease
- cardiovascular disease
- left ventricular